Pharmacokinetics of glycyrrhizin and glycyrrhetic acid following glycyrrhizin administration to rats with single and multiple doses via different routes

Toru Egashira, Fusako Takayama, Fumie Yufu, Yukihiro Shoyama

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Glycyrrhizin (GL) was administered to male rats, intravenously (i.v.), per os (p.o.) with a single bolus (10 mg/kg), or with multiple doses (2mg/kg each, every 24 hours), or intraperitoneally (i.p.) with a single bolus dose (10mg/kg). The plasma GL concentration-time curves obtained after single i.v. or i.p. GL injection closely resembled a 2-compartment model. The plasma GL and glycyrrhetic acid (GA) concentrations following single i.p. administration of GL changed almost identically to their changes following single i.v. case, despite some delay in peak time and a somewhat reduced peak concentration. In the single-dose p.o. case, the GL itself was absorbed very gradually and reached the maximum plasma concentration of about 70ng/mL 10-12h after administration. The amount absorbed up to 24 hours after administration was about 60% of the total. On the other hand, there was no significant difference in the GA behaviors after all routes of single GL administration. In the case of multiple GL doses, the plasma GL level was 2-10 μg/mL by the i.v. route, and 0.2-0.7 μg/mL for the p.o. administration. The plasma GA level was maintained at almost the same concentration ranging from 6-50ng/mL i.v. and 5-60ng/mL p.o., respectively. The results obtained in this study may be useful in establishing an optimal administration method for GL, when GL and GA would individually contribute to both the targeted effects and the adverse effects.

Original languageEnglish
Pages (from-to)75-83
Number of pages9
JournalJapanese Pharmacology and Therapeutics
Volume31
Issue number1
Publication statusPublished - 2003
Externally publishedYes

Fingerprint

Glycyrrhetinic Acid
Glycyrrhizic Acid
Pharmacokinetics

Keywords

  • Bioavailability
  • ELISA
  • Glycyrrhetic acid
  • Glycyrrhizin
  • Pharmacokinetic
  • Rat

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Pharmacology

Cite this

Pharmacokinetics of glycyrrhizin and glycyrrhetic acid following glycyrrhizin administration to rats with single and multiple doses via different routes. / Egashira, Toru; Takayama, Fusako; Yufu, Fumie; Shoyama, Yukihiro.

In: Japanese Pharmacology and Therapeutics, Vol. 31, No. 1, 2003, p. 75-83.

Research output: Contribution to journalArticle

@article{d74c8817387343f682bc903a484815b4,
title = "Pharmacokinetics of glycyrrhizin and glycyrrhetic acid following glycyrrhizin administration to rats with single and multiple doses via different routes",
abstract = "Glycyrrhizin (GL) was administered to male rats, intravenously (i.v.), per os (p.o.) with a single bolus (10 mg/kg), or with multiple doses (2mg/kg each, every 24 hours), or intraperitoneally (i.p.) with a single bolus dose (10mg/kg). The plasma GL concentration-time curves obtained after single i.v. or i.p. GL injection closely resembled a 2-compartment model. The plasma GL and glycyrrhetic acid (GA) concentrations following single i.p. administration of GL changed almost identically to their changes following single i.v. case, despite some delay in peak time and a somewhat reduced peak concentration. In the single-dose p.o. case, the GL itself was absorbed very gradually and reached the maximum plasma concentration of about 70ng/mL 10-12h after administration. The amount absorbed up to 24 hours after administration was about 60{\%} of the total. On the other hand, there was no significant difference in the GA behaviors after all routes of single GL administration. In the case of multiple GL doses, the plasma GL level was 2-10 μg/mL by the i.v. route, and 0.2-0.7 μg/mL for the p.o. administration. The plasma GA level was maintained at almost the same concentration ranging from 6-50ng/mL i.v. and 5-60ng/mL p.o., respectively. The results obtained in this study may be useful in establishing an optimal administration method for GL, when GL and GA would individually contribute to both the targeted effects and the adverse effects.",
keywords = "Bioavailability, ELISA, Glycyrrhetic acid, Glycyrrhizin, Pharmacokinetic, Rat",
author = "Toru Egashira and Fusako Takayama and Fumie Yufu and Yukihiro Shoyama",
year = "2003",
language = "English",
volume = "31",
pages = "75--83",
journal = "Japanese Pharmacology and Therapeutics",
issn = "0386-3603",
publisher = "Life Science Publishing Co. Ltd",
number = "1",

}

TY - JOUR

T1 - Pharmacokinetics of glycyrrhizin and glycyrrhetic acid following glycyrrhizin administration to rats with single and multiple doses via different routes

AU - Egashira, Toru

AU - Takayama, Fusako

AU - Yufu, Fumie

AU - Shoyama, Yukihiro

PY - 2003

Y1 - 2003

N2 - Glycyrrhizin (GL) was administered to male rats, intravenously (i.v.), per os (p.o.) with a single bolus (10 mg/kg), or with multiple doses (2mg/kg each, every 24 hours), or intraperitoneally (i.p.) with a single bolus dose (10mg/kg). The plasma GL concentration-time curves obtained after single i.v. or i.p. GL injection closely resembled a 2-compartment model. The plasma GL and glycyrrhetic acid (GA) concentrations following single i.p. administration of GL changed almost identically to their changes following single i.v. case, despite some delay in peak time and a somewhat reduced peak concentration. In the single-dose p.o. case, the GL itself was absorbed very gradually and reached the maximum plasma concentration of about 70ng/mL 10-12h after administration. The amount absorbed up to 24 hours after administration was about 60% of the total. On the other hand, there was no significant difference in the GA behaviors after all routes of single GL administration. In the case of multiple GL doses, the plasma GL level was 2-10 μg/mL by the i.v. route, and 0.2-0.7 μg/mL for the p.o. administration. The plasma GA level was maintained at almost the same concentration ranging from 6-50ng/mL i.v. and 5-60ng/mL p.o., respectively. The results obtained in this study may be useful in establishing an optimal administration method for GL, when GL and GA would individually contribute to both the targeted effects and the adverse effects.

AB - Glycyrrhizin (GL) was administered to male rats, intravenously (i.v.), per os (p.o.) with a single bolus (10 mg/kg), or with multiple doses (2mg/kg each, every 24 hours), or intraperitoneally (i.p.) with a single bolus dose (10mg/kg). The plasma GL concentration-time curves obtained after single i.v. or i.p. GL injection closely resembled a 2-compartment model. The plasma GL and glycyrrhetic acid (GA) concentrations following single i.p. administration of GL changed almost identically to their changes following single i.v. case, despite some delay in peak time and a somewhat reduced peak concentration. In the single-dose p.o. case, the GL itself was absorbed very gradually and reached the maximum plasma concentration of about 70ng/mL 10-12h after administration. The amount absorbed up to 24 hours after administration was about 60% of the total. On the other hand, there was no significant difference in the GA behaviors after all routes of single GL administration. In the case of multiple GL doses, the plasma GL level was 2-10 μg/mL by the i.v. route, and 0.2-0.7 μg/mL for the p.o. administration. The plasma GA level was maintained at almost the same concentration ranging from 6-50ng/mL i.v. and 5-60ng/mL p.o., respectively. The results obtained in this study may be useful in establishing an optimal administration method for GL, when GL and GA would individually contribute to both the targeted effects and the adverse effects.

KW - Bioavailability

KW - ELISA

KW - Glycyrrhetic acid

KW - Glycyrrhizin

KW - Pharmacokinetic

KW - Rat

UR - http://www.scopus.com/inward/record.url?scp=0037287786&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037287786&partnerID=8YFLogxK

M3 - Article

VL - 31

SP - 75

EP - 83

JO - Japanese Pharmacology and Therapeutics

JF - Japanese Pharmacology and Therapeutics

SN - 0386-3603

IS - 1

ER -